Abstract: Novel imidazopyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a viral infection, in particular a HCV, HRV, Sb and/or CVB in a patient in need thereof.
Type:
Grant
Filed:
August 20, 2008
Date of Patent:
January 29, 2013
Assignee:
Biofocus DPI, Ltd.
Inventors:
Angus MacLeod, Dale Robert Mitchell, Nicholas John Palmer, Michael Daniel Goldsmith, Clifford John Harris, Christophe Claude Parsy